Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 162 of the 163 references it cites were found in a registry or an index.

Biomarkers of neurodegeneration across the Global South

Open access

Abstract

Research on neurodegenerative diseases has predominantly focused on high-income countries in the Global North. This Series paper describes the state of biomarker evidence for neurodegeneration in the Global South, including Latin America, Africa, and countries in south, east, and southeast Asia. Latin America shows growth in fluid biomarker and neuroimaging research, with notable advancements in genetics. Research in Africa focuses on genetics and cognition but there is a paucity of data on fluid and neuroimaging biomarkers. South and east Asia, particularly India and China, has achieved substantial progress in plasma, neuroimaging, and genetic studies. However, all three regions face several challenges in the form of a lack of harmonisation, insufficient funding, and few comparative studies both within the Global South, and between the Global North and Global South. Other barriers include scarce infrastructure, lack of knowledge centralisation, genetic and cultural diversity, sociocultural stigmas, and restricted access to tools such as PET scans. However, the diverse ethnic, genetic, economic, and cultural backgrounds in the Global South present unique opportunities for bidirectional learning, underscoring the need for global collaboration to enhance the understanding of dementia and brain health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2666-7568(24)00132-6

Cites

162 of 162 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1: Participant distribution in studies included in the selective review per biomarker type across the Global South Heatmap illustrating the number of participants included in the selected biomarker studies across countries in the Global South. The figure illustrates the included studies across all types of neurodegenerative diseases across the different biomarker types: fluid biomarkers including plasma and CSF (A), cognitive studies (B), neuroimaging studies (C), and genetic studies (D). Due to the large number of controls in some genetic studies, figures for genetic studies exclude number of controls. CSF=cerebrospinal fluid.
Figure 1: Participant distribution in studies included in the selective review per biomarker type across the Global South Heatmap illustrating the number of participants included in the selected biomarker studies across countries in the Global South. The figure illustrates the included studies across all types of neurodegenerative diseases across the different biomarker types: fluid biomarkers including plasma and CSF (A), cognitive studies (B), neuroimaging studies (C), and genetic studies (D). Due to the large number of controls in some genetic studies, figures for genetic studies exclude number of controls. CSF=cerebrospinal fluid.CC BY · PubMed Central
Figure 2: Multisectoral responses to challenges in biomarker research and potential effects in the Global South Challenges faced by biomarker research in the Global South and potential solutions are illustrated. Identified challenges such as stigma, validation of biomarkers, infrastructure, and funding require multisectoral solutions across cultural, research, and policy sectors. Suggested research and policy priorities to address these challenges are described. The effects of and potential for biomarker research at a global scale should multiple sectors work together to actualise these priorities are highlighted.
Figure 2: Multisectoral responses to challenges in biomarker research and potential effects in the Global South Challenges faced by biomarker research in the Global South and potential solutions are illustrated. Identified challenges such as stigma, validation of biomarkers, infrastructure, and funding require multisectoral solutions across cultural, research, and policy sectors. Suggested research and policy priorities to address these challenges are described. The effects of and potential for biomarker research at a global scale should multiple sectors work together to actualise these priorities are highlighted.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 163 references

Research works printed but not linked: 2

  1. Sjahrir, 2001, The Mini Mental State Examination in healthy individuals in Medan, Indonesia by age and education level, Neurol J Seast Asia, 6, 19
  2. Miranda, 2017, Abnormal expansion of C9orf72 gene in familial frontotemporal dementia, Rev Med Chil, 145, 896

Cited by

See all 44

Metadata

Authors
McGlinchey, E., Duran-Aniotz, C., Akinyemi, R., Arshad, F., Zimmer, E. R., Cho, H., Adewale, B. A., & Ibanez, A.
Affiliations
  • University of California, San Francisco (US)
  • Adolfo Ibáñez University (CL)
  • Universidade Federal do Rio Grande do Sul (BR)
  • University of Ibadan (NG)
Corresponding author
McGlinchey, Eimear
Venue
The Lancet Healthy Longevity
Publisher
Elsevier BV
Published
2024-10
Volume
5
Issue
10
Pages
100616
ISSN
2666-7568 (ISSN-L)
OpenAlex
W4403087807
Cited by
32
References
163
Citations by year
2026: 11 · 2025: 19 · 2024: 2
FWCI
2.54
Type
journal article
Language
en
Update notices
erratum (2024-11-01)
Open access
Licence
Locations
  • The Lancet Healthy Longevity (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Alzheimer's Association (20-725707, SG-20- 725707, AARGD-21-850670, Serra-1912-31365)
  • Global Brain Health Institute
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (409066/2022-2, 312306/2021-0, 435642/2018- 9, 465671/2014‐4, 312410/2018‐2, 21/2551-0000673-0, 2014-4, 16/2551‐0000475‐7)
  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (16/2551–0000475–7, 2014-4, 16/2551, 21/2551- 0000673-0)
  • Instituto Nacional de Ciência e Tecnologia para Excitotoxicidade e Neuroproteção (# 465671/2014-4)
  • Instituto Serrapilheira (Serra‐1912‐31365)
  • Agencia Nacional de Investigación y Desarrollo (ANID/PIA/ANILLOS ACT210096, ACT210096, FONDAP-15150012, PIA/ANILLOS ACT210096, 15150012, ID20I10152, 1210195, 1210622, 1210176, 1220995)
  • National Institutes of Health (15150012)
  • National Institute on Aging (R01AG057234, R01AG072547, P01AG019724, U19AG074865, R01AG075775)
  • Fogarty International Center
  • Fondo de Fomento al Desarrollo Científico y Tecnológico (ID20I10152)
  • Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias (15150012)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
neurodegenerative diseases, biomarkers, Global South, dementia, fluid biomarkers, neuroimaging biomarkers, genetic biomarkers, plasma biomarkers, Latin America, Africa, South and East Asia, international cooperation, brain health, sociocultural stigma
MeSH terms
Africa, Humans, Latin America, Global Health, Biomarkers, Neurodegenerative Diseases, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biomarkers of neurodegeneration across the Global South. https://app.cochat.ai/papers/10.1016/s2666-7568(24)00132-6
The paper
McGlinchey, E., Duran-Aniotz, C., Akinyemi, R., Arshad, F., Zimmer, E. R., Cho, H., Adewale, B. A., & Ibanez, A. (2024). Biomarkers of neurodegeneration across the Global South. The Lancet Healthy Longevity. https://doi.org/10.1016/s2666-7568(24)00132-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.